Post Reply
781-800 of 10899
i agree he is still inside and wish to cap the growth.... but i really do not understand his motive....
infancybird ( Date: 01-Feb-2013 16:25) Posted:
lately trading volume has been quite big and hence it is difficult to detect the whereabout of this i-seller. My gut feeling is he is still out there interfering the advance of Bio price. High volume is against his sales strategy but once the trading volume comes down he will reappear to whack his tail again. I am still monitoring him.
ericpang ( Date: 31-Jan-2013 22:26) Posted:
Hm... Looks like time for next up swing |
|
|
|
lately trading volume has been quite big and hence it is difficult to detect the whereabout of this i-seller. My gut feeling is he is still out there interfering the advance of Bio price. High volume is against his sales strategy but once the trading volume comes down he will reappear to whack his tail again. I am still monitoring him.
ericpang ( Date: 31-Jan-2013 22:26) Posted:
Hm... Looks like time for next up swing |
|
lets wait and see result on 7 feb... 2013... (I just read this company profile have very good protential to hold strong) this company make very good profit surely grow.... all the way...
com'on jia you!!! should i buy more now?? scali 7 feb is big ang pow )
Hm... Looks like time for next up swing
tonight Terumo announcing their quarterly results so roughly can have an idea what to expect on 7th Feb.
Have patience and faith in your counter. Bio investors( not short term punter) need to just wait for 8 more days for the coy to announce 3rd Q result (on 7th Feb) and its imminent M& A ( very sure of this acquisition to happen very soon, may be on 8th Feb as a CNY angbao for us ) . These are positive news and will push the stk higher. Whatever happens now is just a healthy correction , a chance for the BB to accumulate more shares and for weak holder to take profit & leave the mkt. You can`t expect the price to keep shooting upwards day after day. It has gone up 20cents last two months, thats a lot to me.
bishan22 ( Date: 31-Jan-2013 16:45) Posted:
Haha. You have to interpret my comment with a pinch of salt. Market have no mercy for all investors. 
srichipan ( Date: 31-Jan-2013 11:47) Posted:
| Yah. Don't just use the word signal to make yourself look like v pro leh. I think he just meant ppl taking profits. |
|
|
|
Haha. You have to interpret my comment with a pinch of salt. Market have no mercy for all investors.
srichipan ( Date: 31-Jan-2013 11:47) Posted:
Yah. Don't just use the word signal to make yourself look like v pro leh. I think he just meant ppl taking profits.
raykee ( Date: 31-Jan-2013 10:53) Posted:
| What signal? Tmd lor correction so fas |
|
|
|
If 8feb really results release not enuf time to cash out for cby... Hmmmm i feel can hit 1.5x what is the pull back factr?
If the counter went up by biggest volume, I think BB dont just take a few cents profit, need more patience to let profit run unless 3rd quarter report NG
Yah. Don't just use the word signal to make yourself look like v pro leh. I think he just meant ppl taking profits.
raykee ( Date: 31-Jan-2013 10:53) Posted:
What signal? Tmd lor correction so fast
bishan22 ( Date: 31-Jan-2013 09:58) Posted:
|
Yesterday signal was bad. Dumped at 1.39. Satisfied already. Good luck. |
|
|
|
looks dropping to 1.34...
What signal? Tmd lor correction so fast
bishan22 ( Date: 31-Jan-2013 09:58) Posted:
|
Yesterday signal was bad. Dumped at 1.39. Satisfied already. Good luck. |
|
i think many people kenna scarred by biosensors before last year, so many might easily run at the first sight of shorting frenzy for this stock
raykee ( Date: 31-Jan-2013 09:22) Posted:
| the fall is really huge lor... why ppl wanna sell at lower price? need some enlightenment, to cause panic and buy more? |
|
Yesterday signal was bad. Dumped at 1.39. Satisfied already. Good luck.
the fall is really huge lor... why ppl wanna sell at lower price? need some enlightenment, to cause panic and buy more?
Nobody ever got killed taking profits, friend starlene. So, you are going for $200,000?
What a master trader you are!
CHINA/HEALTHCARE
Stock Rating:
OUTPERFORM
12-18 mo. Price Target SGD1.80
BIG:SP - SES SGD1.33
3-5 Yr. EPS Gr. Rate 13%
52-Wk Range SGD1.70-SGD1.03
Shares Outstanding 1,751.0M
Float 1,080.0M
Market Capitalization SGD2,277.4M
Avg. Daily Trading Volume 5,670,588
Fiscal Year Ends Mar
2013E ROE 2.4 %
Biosensors International
An Innovative DES Player Gaining Global Traction
Initiate with Outperform
SUMMARY
We initiate coverage of Biosensors (BIG:SP or SGX:B20.SI) with an Outperform.
Biosensors is a Singaporean coronary stent developer and manufacturer with global
operations. It is among the promising innovative Asian med tech companies that we
liken to the Japanese auto companies in the 1970s. Biosensors excels at drug-eluting
stents and adopts various distribution methods that fit different markets to promote
its products successfully. It's leading in China's DES market, and taking share and
growing at double-digits in Europe. We expect Biosensors to grow revenue/EPS at
16.6%/12.9% 2012-2015 CAGRs. The stock trades at 13x/11x our FY14E/15E EPS
estimates of SGD0.10/0.12. Our PT implies 18x our FY14E EPS of S$0.10.
KEY POINTS
■
of the promising Asian innovative medical device companies. It has developed
expertise in the cardiovascular device area and plans to expand into multiple highvalue
medical device segments. We believe it could evolve into a global leader.
An Innovative Asian Medical Device Company. We view Biosensors as one
■
markets. We estimate Excel, Biosensors' DES, holds 22.9% market share in
China. We estimate Biosensors will deliver a 15% 5-year CAGR in China.
BioMatrix Flex’s potential SFDA approval could further enhance its leadership.
Leader in China. The DES (drug-eluting stent) market is growing fast in emerging
■
approval on January 28th, a near-term catalyst for the stock and a long-term
revenue growth driver. Biosensors' recent debt offering and our recent meeting
with management suggest to us the company could soon undertake M& A activity
to diversify into new medical device areas.
R& D and M& A. BioFreedom, Biosensors' polymer-free DES, gained CE Mark
■
believe the stock is attractive based on our 12- to 18-month PT of SGD1.80,
implying 18x our FY14E EPS and 35% upside potential.
Valuation Attractive. We expect 3-year revenue/EPS CAGRs at 16.6%/12.9%
This research report is intended for use only by institutions to which the
subject security or securities may be sold pursuant to an exemption from stat
ppenheimer & Co Inc. 85 Broad Street, New York, NY 10004 Tel: 800-221-5588 Fax: 212-667-8229
Ingrid Yin, Ph.D.
212-667-7194
Ingrid.Yin@opco.com
Oppenheimer & Co. Inc. does and seeks to do business with companies covered
in its research reports. As a result, investors should be aware that the firm may
have a conflict of interest that could affect the objectivity of this report. Investors
should consider this report as only a single factor in making their investment
decision. See " Important Disclosures and Certifications" section at the end of
this report for important disclosures, including potential conflicts of interest. See
" Price Target Calculation" and " Key Risks to Price Target" sections at the end of
this report, where applicable.
Stock Price Performance Company Description
The Biosensors International group of
companies develops, manufactures and
markets innovative medical devices for
interventional cardiology and critical
care procedures, and is headquartered
in Singapore.
January 28, 2013
worried liao.... today the fall is..... highest peak at 1.42 only burst 1 day... dun tell me that ass is still ard?
good time to go in again for next wave.
